Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2
Journal
Molecular Cell
Journal Volume
6
Journal Issue
3
Date Issued
2000-01-01
Author(s)
Schwaller, Juerg
Parganas, Evan
Wang, Demin
Cain, Danielle
Aster, Jon C.
Williams, Ifor R.
Gerthner, Rachel
Kitamura, Toshio
Frantsve, Julie
Anastasiadou, Ema
Loh, Mignon L.
Levy, David E.
Ihle, James N.
Gilliland, D. Gary
Abstract
STAT5 is activated in a broad spectrum of human hematologic malignancies. We addressed whether STAT5 activation is necessary for the myelo- and lymphoproliferative disease induced by TEL/JAK2 using a genetic approach. Whereas mice transplanted with bone marrow transduced with retrovirus expressing TEL/JAK2 develop a rapidly fatal myelo- and lymphoproliferative syndrome, reconstitution with bone marrow derived from Stat5ab-deficient mice expressing TEL/JAK2 did not induce disease. Disease induction in the Stat5a/b-deficient background was rescued with a bicistronic retrovirus encoding TEL/JAK2 and Stat5a. Furthermore, myeloproliferative disease was induced by reconstitution with bone marrow cells expressing a constitutively active mutant, Stat5a, or a single Stat5a target, murine oncostatin M (mOSM). These data define a critical role for Stat5a/b and mOSM in the pathogenesis of TEL/JAK2 disease.
SDGs
Type
journal article